Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...

Humana faces industry headwinds with Medicare Advantage pressures, but management maintains 2025 earnings guidance and steady operational performance. HUM stock trades at a discount to peers, ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Myles is a former senior insurance editor for Investopedia. He oversaw the strategy ...

Key Takeaways Obamacare premiums have skyrocketed in 2026, prompting people to consider health insurance alternatives as the Jan. 15 end date for open enrollment approaches.Alternatives such as ...